Search company, investor...


Founded Year



Series B | Alive

Total Raised


Last Raised

$1.48M | 19 yrs ago

About Glycoform

GlycoForm is a biotechnology company with a core expertise and intellectual property in sugar chemistry and protein glycosylation.

Headquarters Location

Unit 44C Milton Park

Oxfordshire, England, OX14 4RU,

United Kingdom

Missing: Glycoform's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Glycoform's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Glycoform News

Bristol Myers Squibb : Researchers at Bristol-Myers Squibb Report New Data on Chromatography (Heterogeneous glycoform separation by process chromatography: I Monomer...

Jul 23, 2015

(You can enter multiple email addresses separated by commas) Message : *Required fields Researchers at Bristol-Myers Squibb Report New Data on Chromatography (Heterogeneous glycoform separation by process chromatography: I Monomer purification and characterization) By a News Reporter-Staff News Editor at Science Letter -- Current study results on Science have been published. According to news reporting out of Hopewell, New Jersey , by NewsRx editors, research stated, "Fc fusion proteins with high and low sialylation were purified and separated by preparative ion-exchange and hydrophobic interaction chromatography. Heterogeneity in sialylation and glycosylation led to variation in surface charge and hydrophobicity, and resulted in multiple distinct glycoform populations in response to various purification conditions. " Our news journalists obtained a quote from the research from Bristol-Myers Squibb , "Monomer with high sialic acid content has higher surface charge and adsorbs stronger to ion-exchange resin, while the less sialylated monomer interacts more favorably with hydrophobic resin. Extensive biophysical characterization was carried out for purified monomers at different level of sialylation. In general, different monomeric glycoforms have different surface charge and hydrophobicity, different thermal stability, and different aggregation propensity. The surface charge corresponds well with sialic acid content, as evidenced by electrophoresis, N-link domain analysis, and zeta potential results. The sialylation also contributes to minor modification of protein size, molecular mass and tertiary structure. Notably, fluorescence emission spectra and thermal transition became less distinguishable when the monomers containing low and high sialic acid were prepared in high ionic strength solution. Such finding reiterates the fact that the electrostatic forces, which are largely dependent on sialic acid content of protein, plays a dominant role in many intra- and inter-molecular interactions. " According to the news editors, the research concluded: "Overall, the characterization data agreed well with separation behaviors and provided valuable insight to control of glycoform profile in purification process. " For more information on this research see: Heterogeneous glycoform separation by process chromatography: I Monomer purification and characterization. Journal of Chromatography A

Glycoform Frequently Asked Questions (FAQ)

  • When was Glycoform founded?

    Glycoform was founded in 2002.

  • Where is Glycoform's headquarters?

    Glycoform's headquarters is located at Unit 44C, Oxfordshire.

  • What is Glycoform's latest funding round?

    Glycoform's latest funding round is Series B.

  • How much did Glycoform raise?

    Glycoform raised a total of $1.48M.

  • Who are the investors of Glycoform?

    Investors of Glycoform include IP Group, East Hill Management Co., Oxford University Innovation and Spark Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.